Wasting cash--the decline of the British biotech sector.
Undercapitalization and overgenerous boardroom compensation for management have been major contributors to the poor performance of UK biotech.
Smith
Graham
G
Akram
Muhammad Safwan
MS
Redpath
Keith
K
Bains
William
W
D001709:Biotechnology / Q000191:economics*; D002202:Capital Financing / Q000191:economics; D006801:Humans; D017149:Private Sector; D012456:Salaries and Fringe Benefits; D006113:United Kingdom